Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × CF regimen × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Cisplatin 11 pembrolizumab 8 Paclitaxel 7 Drug Therapy 6 Irinotecan 4 Fluorouracil 4 Carboplatin 4 toripalimab 3 Radiotherapy 3 tislelizumab 2 nimotuzumab 2 Oxaliplatin 2 Nivolumab 2 Levoleucovorin 2 Leucovorin 2 Docetaxel 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 regorafenib 1 osimertinib 1 nedaplatin 1 lenvatinib 1 futibatinib 1 durvalumab 1 camrelizumab 1 atezolizumab 1 aflibercept 1 Tiragolumab 1 Surgical Procedures, Operative 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04550260 2026-01-29

KUNLUN

AstraZeneca

Phase 3 Active not recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡